Gain Therapeutics, Inc. (GANX) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$1,738
Total Return
-82.62%
CAGR
-29.53%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -0.17% |
| Median | -4.36% |
| Best | +110.84% |
| Worst | -55.38% |
| % of Windows Positive | 39.2% |
1-Year (252 Trading Days)
| Average | -13.68% |
| Median | -17.36% |
| Best | +148.47% |
| Worst | -75.11% |
| % of Windows Positive | 31.5% |
3-Year (756 Trading Days)
| Average | -53.75% |
| Median | -55.71% |
| Best | +32.79% |
| Worst | -89.38% |
| % of Windows Positive | 4.6% |
Risk Metrics
| Maximum Drawdown | -91.21% |
| Average Drawdown | -66.94% |
| Drawdown Duration | 1252 Trading Days (Unrecovered) |
| Sortino Ratio | 0.04 |
| Calmar Ratio | -0.32 |
| CVaR (5%) | -11.21% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -44.41% (-75.16% ann.) | $4441.00 | $0.00 | $0.00 | $0.00 |
| 2025 | +49.07% | +$4907.40 | $0.00 | $0.00 | $0.00 |
| 2024 | -33.84% | $3384.39 | $0.00 | $0.00 | $0.00 |
| 2023 | +4.31% | +$431.33 | $0.00 | $0.00 | $0.00 |
| 2022 | -42.36% | $4235.74 | $0.00 | $0.00 | $0.00 |
| 2021 partial | -55.49% (-64.31% ann.) | $5549.18 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Reopening reflation / fiscal boom / supply bottlenecks partial | March 19, 2021 – November 29, 2021 | -37.54% | -49.04% | $3754.10 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -57.60% | -59.79% | $5759.68 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -52.84% | -33.34% | $5283.91 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | +20.95% | +11.79% | +$2094.62 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.